Contact this trialFirst, we need to learn more about you.
Cholesterol Absorption Inhibitor
Ezetimibe 10mg +2 More for Type 2 Diabetes
Recruiting3 awardsPhase 4
New York, New York
This trial is investigating the difference in heart disease risk factors for those with type 2 diabetes and those without the condition. Cholesterol-lowering medication will be given to participants in order to better understand how diabetes contributes to an increased risk for heart disease and stroke, even after cholesterol is reduced.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service